Angela shares her experience with breast cancer - from diagnosis and treatment to recurrence monitoring with circulating-tumor DNA (ctDNA) testing through Signatera™. https://www.natera.com/oncology/signa...

Signatera is a highly sensitive and personalized molecular residual disease assay (MRD) using tumor-informed ctDNA testing for breast cancer detecting molecular residual disease to inform critical decisions for care.